Amblyopia Market Information: By Type (Strabismus Amblyopia, Refractive Amblyopia), Diagnosis (Visual Acuity Tests, Photo Screening), Treatment (Eye Patches, Atropine Drops, Glasses, Video Game), End-User (Ophthalmic Clinics) - Global Forecast Till 2023

Amblyopia Market Information: By Type (Strabismus Amblyopia, Refractive Amblyopia), Diagnosis (Visual Acuity Tests, Photo Screening), Treatment (Eye Patches, Atropine Drops, Glasses, Video Game), End-User (Ophthalmic Clinics) - Global Forecast Till 2023


  • Products Id :- MRFR/HC/2967-CRR
  • |
  • Pages: 108
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Amblyopia Market Information: By Type (Strabismus Amblyopia, Refractive Amblyopia), Diagnosis (Visual Acuity Tests, Photo Screening), Treatment (Eye Patches, Atropine Drops, Glasses, Video Game), End-User (Ophthalmic Clinics)-Global Forecast Till 2023

Market Analysis

Amblyopia is a disorder of the eye which prompts diminished vision in one or both the eyes because of stifled input from the brain. The most well-known reason for amblyopia is a refractive error in one or both the eyes, or it may even happen because of muscle irregularity. The other reason for amblyopia is if a baby is born with the cataract issue, then it could cause the baby to see cloudy pictures. There are four major types of amblyopia, including Refractive Amblyopia, Deprivation Amblyopia, Strabismus Amblyopia, and Reverse Amblyopia. The Global amblyopia market is projected to grow rapidly at a CAGR of 3.80% during the prediction period 2017-2023.

Amblyopia is present in 2% to 3% of the infant population world over. The global Amblyopia market is mainly getting driven by the increasing incidences of ophthalmological disorders like cataracts, glaucoma, macular degeneration, and other refractive errors. With the growing prevalence of ophthalmological disorders, there is an increasing demand for the proper treatment of the disorder.

Market Segmentation

The global amblyopia market is bifurcated on the basis of its type, treatment, diagnosis, end-user, and geographical analysis. Based on its type, the market is segmented into Refractive Amblyopia, Deprivation Amblyopia, Strabismus Amblyopia, Reverse Amblyopia, and others. On the basis of its diagnosis, the global market is segmented into photo screening, visual acuity tests, Bruckner test, and others. Based on its treatment, the global amblyopia market is segmented into atropine drops, eye patches, video game, glasses, and others. On the basis of its end-user industry, it is divided into ophthalmic clinics, hospitals & pharmacies, and others.

Regional Analysis

Geographically, the global amblyopia market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major Players

The major industry players in the global amblyopia market are Amblyotech, Inc, Amblyoptica (Holding) Pty Ltd, Good-Lite Co, Cooper Vision, Vivid Vision, Inc., Johnson & Johnson, Carl Zeiss AG, Novartis AG., HOYA Corporation, Fresnel Prism and Lens Co., Krafty Eye Patches, McKesson Corporation, Hilco Vision, and others.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents:

1 Report Prologue

2 Introduction

2.1 Market Definition

2.2 Scope of Study

2.3 Research Objective

2.4 Assumptions & Limitations

2.4.1 Assumptions

2.4.2 Limitations

3 Research Methodology

3.1.1 Primary Research Methodology

3.1.2 Secondary Research Methodology

3.1.3 Market Share Analysis

3.1.4 Market Pricing Approach

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Increasing Prevalence of Ophthalmological Disorders

4.2.2 Favorable Government Funding

4.2.3 Product Advancements

4.3 Restraints

4.3.1 Lack of Awareness

4.3.2 Longer Duration of Treatment

4.4 Opportunity

4.4.1 Entering untapped markets

4.5 Mega Trend

4.5.1 Technological Trends

4.6 Macroeconomics

5 Market Factor Analysis

5.1 Value Chain Analysis

5.1.1 R&D

5.1.2 Manufacturing

5.1.3 Distribution & Sales

5.1.4 Post-sales Monitoring

5.2 Porter's Five Forces Model

5.2.1 Bargaining Power of Suppliers

5.2.2 Bargaining Power of Buyers

5.2.3 Threat of New Entrants

5.2.4 Threat of Substitutes

5.2.5 Intensity of Rivalry

5.3 Investment Opportunities

5.4 Pricing Analysis

5.5 Demand & Supply: Gap Analysis

6 Global Amblyopia Market By Type

6.1 Introduction

6.1.1 Strabismus Amblyopia

6.1.2 Refractive Amblyopia

6.1.3 Deprivation Amblyopia

6.1.4 Reverse Amblyopia

7 Global Amblyopia Market By Diagnosis

7.1 Introduction

7.1.1 Visual acuity tests

7.1.2 Photo screening

7.1.3 Bruckner test

8 Global Amblyopia Market By Treatment

8.1 Introduction

8.1.1 Eye Patches

8.1.2 Atropine Drops

8.1.3 Glasses

8.1.4 Video game

9 Global Amblyopia Market By End User

9.1 Introduction

9.1.1 Hospitals & Pharmacies

9.1.2 Ophthalmic Clinics

10 Global Amblyopia Market By Region

10.1 Americas

10.1.1 North America

10.1.1.1 U.S.

10.1.1.2 Canada

10.1.2 South America

10.2 Europe

10.2.1 Western Europe

10.2.1.1 Germany

10.2.1.2 France

10.2.1.3 U.K.

10.2.1.4 Italy

10.2.1.5 Spain

10.2.1.6 Rest of Western Europe

10.2.2 Eastern Europe

10.3 Asia Pacific

10.3.1 Japan

10.3.2 China

10.3.3 India

10.3.4 Australia

10.3.5 Republic of Korea

10.3.6 Rest of Asia Pacific

10.4 Middle East & Africa

10.4.1 Middle East

10.4.2 Africa

11 Company Landscape

11.1 Key Player Analysis, by Product

11.1.1 Patches

11.1.2 Video Games

11.1.3 Glasses

11.2 Key Growth Strategy Analysis

11.3 Recent key developments

12 Company Profile

12.1 Amblyoptica (Holding) Pty Ltd

12.1.1 Company Overview

12.1.2 Financials

12.1.3 Products

12.1.4 Strategy

12.1.5 Key Developments

12.2 Amblyotech, Inc.

12.2.1 Company Overview

12.2.2 Financials

12.2.3 Products

12.2.4 Strategy

12.2.5 Key Developments

12.3 Good-Lite Co

12.3.1 Company Overview

12.3.2 Financials

12.3.3 Products

12.3.4 Strategy

12.3.5 Key Developments

12.4 Vivid Vision, Inc.

12.4.1 Company Overview

12.4.2 Financials

12.4.3 Products

12.4.4 Strategy

12.4.5 Key Developments

12.5 CooperVision

12.5.1 Company Overview

12.5.2 Financials

12.5.3 Products

12.5.4 Strategy

12.5.5 Key Developments

12.6 Johnson & Johnson

12.6.1 Company Overview

12.6.2 Financials

12.6.3 Products

12.6.4 Strategy

12.6.5 Key Developments

12.7 Novartis AG.

12.7.1 Company Overview

12.7.2 Financials

12.7.3 Products

12.7.4 Strategy

12.7.5 Key Developments

12.8 Carl Zeiss AG

12.8.1 Company Overview

12.8.2 Financials

12.8.3 Products

12.8.4 Strategy

12.8.5 Key Developments

12.9 HOYA Corporation

12.9.1 Company Overview

12.9.2 Financials

12.9.3 Products

12.9.4 Strategy

12.9.5 Key Developments

12.1 Krafty Eye Patches.

12.10.1 Company Overview

12.10.2 Financials

12.10.3 Products

12.10.4 Strategy

12.10.5 Key Developments

12.11 Fresnel Prism and Lens Co.

12.11.1 Company Overview

12.11.2 Financials

12.11.3 Products

12.11.4 Strategy

12.11.5 Key Developments

12.12 Hilco Vision

12.12.1 Company Overview

12.12.2 Financials

12.12.3 Products

12.12.4 Strategy

12.12.5 Key Developments

12.13 McKesson Corporation

12.13.1 Company Overview

12.13.2 Financials

12.13.3 Products

12.13.4 Strategy

12.13.5 Key Developments

13 Conclusion

13.1 Key Findings

13.1.1 The CEO's Viewpoint

13.1.2 Unmet Needs

13.1.3 Key Companies to Watch

13.1.4 Prediction of Amblyopia Industry

14 Appendix

14.1 Discussion Blue Print

14.2 References

List of Figures:

FIGURE 1 GLOBAL AMBLYOPIA MARKET

FIGURE 2 RESEARCH METHODOLOGY

FIGURE 3 GLOBAL AMBLYOPIA MARKET: FORECAST MODEL

FIGURE 4 VALUE CHAIN-GLOBAL AMBLYOPIA MARKET

FIGURE 5 PORTERS FIVE FORCES MODEL-GLOBAL AMBLYOPIA MARKET

FIGURE 6 GLOBAL AMBLYOPIA MARKET, BY TYPE 2017 & 2023 (USD MILLION)

FIGURE 7 GLOBAL AMBLYOPIA MARKET, BY TREATMENT 2017 & 2023 (USD MILLION)

FIGURE 8 GLOBAL AMBLYOPIA MARKET, BY END USER 2017 & 2023 (USD MILLION)

FIGURE 9 GLOBAL AMBLYOPIA MARKET, BY REGION 2017 & 2023 (USD MILLION)

FIGURE 10 AMERICAS AMBLYOPIA MARKET, BY REGION 2017 & 2023 (USD MILLION)

FIGURE 11 NORTH AMERICA AMBLYOPIA MARKET, BY COUNTRY 2017 & 2023 (USD MILLION)

FIGURE 12 EUROPE AMBLYOPIA MARKET, BY REGION 2017 & 2023 (USD MILLION)

FIGURE 13 WESTERN EUROPE AMBLYOPIA MARKET, BY COUNTRY 2017 & 2023 (USD MILLION)

FIGURE 14 ASIA PACIFIC AMBLYOPIA MARKET, BY COUNTRY 2017 & 2023 (USD MILLION)

FIGURE 15 MIDDLE EAST & AFRICA AMBLYOPIA MARKET, BY REGION 2014-2023 (USD MILLION)

List of Tables:

TABLE 1 PRIMARY INTERVIEWS

TABLE 2 GLOBAL AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 3 GLOBAL AMBLYOPIA MARKET, BY STRABISMUS AMBLYOPIA 2014-2023 (USD MILLION)

TABLE 4 GLOBAL AMBLYOPIA MARKET, BY REFRACTIVE AMBLYOPIA 2014-2023 (USD MILLION)

TABLE 5 GLOBAL AMBLYOPIA MARKET, BY DEPRIVATION AMBLYOPIA 2014-2023 (USD MILLION)

TABLE 6 GLOBAL AMBLYOPIA MARKET, BY REVERSE AMBLYOPIA 2014-2023 (USD MILLION)

TABLE 7 GLOBAL AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 8 GLOBAL AMBLYOPIA MARKET, EYE PATCHES 2014-2023 (USD MILLION)

TABLE 9 GLOBAL AMBLYOPIA MARKET, ATROPINE DROPS 2014-2023 (USD MILLION)

TABLE 10 GLOBAL AMBLYOPIA MARKET, GLASSES 2014-2023 (USD MILLION)

TABLE 11 GLOBAL AMBLYOPIA MARKET, VIDEO GAME 2014-2023 (USD MILLION)

TABLE 12 GLOBAL AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 13 GLOBAL AMBLYOPIA MARKET, HOSPITALS & PHARMACIES 2014-2023 (USD MILLION)

TABLE 14 GLOBAL AMBLYOPIA MARKET, OPHTHALMIC CLINICS 2014-2023 (USD MILLION)

TABLE 15 GLOBAL AMBLYOPIA MARKET, BY REGION 2014-2023 (USD MILLION)

TABLE 16 AMERICAS AMBLYOPIA MARKET, BY REGION 2014-2023 (USD MILLION)

TABLE 17 AMERICAS AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 18 AMERICAS AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 19 AMERICAS AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 20 NORTH AMERICA AMBLYOPIA MARKET, BY COUNTRY 2014-2023 (USD MILLION)

TABLE 21 NORTH AMERICA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 22 NORTH AMERICA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 23 NORTH AMERICA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 24 U.S. AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 25 U.S. AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 26 U.S. AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 27 CANADA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 28 CANADA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 29 CANADA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 30 SOUTH AMERICA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 31 SOUTH AMERICA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 32 SOUTH AMERICA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 33 EUROPE AMBLYOPIA MARKET, BY REGION 2014-2023 (USD MILLION)

TABLE 34 EUROPE AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 35 EUROPE AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 36 EUROPE AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 37 WESTERN EUROPE AMBLYOPIA MARKET, BY COUNTRY 2014-2023 (USD MILLION)

TABLE 38 WESTERN EUROPE AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 39 WESTERN EUROPE AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 40 WESTERN EUROPE AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 41 GERMANY AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 42 GERMANY AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 43 GERMANY AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 44 FRANCE AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 45 FRANCE AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 46 FRANCE AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 47 U.K. AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 48 U.K. AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 49 U.K. AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 50 ITALY AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 51 ITALY AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 52 ITALY AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 53 SPAIN AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 54 SPAIN AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 55 SPAIN AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 56 REST OF WESTERN EUROPE AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 57 REST OF WESTERN EUROPE AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 58 REST OF WESTERN EUROPE AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 59 EASTERN EUROPE AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 60 EASTERN EUROPE AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 61 EASTERN EUROPE AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 62 ASIA PACIFIC AMBLYOPIA MARKET, BY COUNTRY 2014-2023 (USD MILLION)

TABLE 63 ASIA PACIFIC AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 64 ASIA PACIFIC AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 65 ASIA PACIFIC AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 66 JAPAN AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 67 JAPAN AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 68 JAPAN AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 69 CHINA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 70 CHINA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 71 CHINA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 72 INDIA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 73 INDIA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 74 INDIA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 75 AUSTRALIA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 76 AUSTRALIA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 77 AUSTRALIA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 78 REPUBLIC OF KOREA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 79 REPUBLIC OF KOREA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 80 REPUBLIC OF KOREA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 81 REST OF ASIA PACIFIC AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 82 REST OF ASIA PACIFIC AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 83 REST OF ASIA PACIFIC AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 84 MIDDLE EAST & AFRICA AMBLYOPIA MARKET, BY REGION 2014-2023 (USD MILLION)

TABLE 85 MIDDLE EAST & AFRICA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 86 MIDDLE EAST & AFRICA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 87 MIDDLE EAST & AFRICA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 88 MIDDLE EAST AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 89 MIDDLE EAST AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 90 MIDDLE EAST AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 91 AFRICA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION)

TABLE 92 AFRICA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION)

TABLE 93 AFRICA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION)

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Amblyotech, Inc, Amblyoptica (Holding) Pty Ltd, Good-Lite Co, Cooper Vision, Vivid Vision, Inc., Johnson & Johnson, Carl Zeiss AG, Novartis AG., HOYA Corporation, Fresnel Prism and Lens Co., Krafty Eye Patches, McKesson Corporation, Hilco Vision, and others

select a license
Single User License
USD 4450 INR 307807
Corporate User License
USD 6250 INR 432313

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com